Impairment of liver regeneration by the histone deacetylase inhibitor valproic acid in mice

Journal of Zhejiang University: Science B

Volumn 13, Issue 9, 2012, Pages 695-706

  Ke, Qi ^a   Yang, Rui Na ^a,b   Ye, Feng ^a   Wang, Yu Jia ^a   Wu, Qiong ^a   Li, Li ^a   Bu, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

B myc; Cell cycle; Epigenetic factors; Liver regeneration; VPA

Indexed keywords

BROXURIDINE; COMPLEMENTARY DNA; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; HISTONE DEACETYLASE; KI 67 ANTIGEN; MYC PROTEIN; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; HISTONE ACETYLATION; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; CELL PROLIFERATION; CYCLINS; EPIGENESIS, GENETIC; HEPATECTOMY; HEPATOCYTES; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION, GENETIC; VALPROIC ACID;

MUS;

EID: 84866045219     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1100362     Document Type: Article

References (41)

1. Asker, C., Magnusson, K.P., Piccoli, S.P., Andersson, K., Klein, G., Cole, M.D., Wiman, K.G., 1995. Mouse and rat B-myc share amino acid sequence homology with the C-myc transcriptional activator domain and contain a B-myc specific carboxyl terminal region. Oncogene, 11(10):1963-1969.
2. Awad, M.M., Gruppuso, P.A., 2000. Cell cycle control during liver development in the rat: evidence indicating a role for cyclin D1 posttranscriptional regulation 1. Cell Growth Differ., 11(6):325-334.
3. Bartolini, G., Orlandi, M., Papi, A., Ammar, K., Tonelli, R., Franzoni, M., Pession, A., Rocchi, P., Ferreri, A.M., 2008. Growth inhibition and proapoptotic activity induction by IIF and valproic acid on RA-resistant leukemia cells. Anticancer Res., 28(1A):283-288.
4. Burton, R.A., Mattila, S., Taparowsky, E.J., Post, C.B., 2006. B-myc: N-terminal recognition of myc binding proteins. Biochemistry, 45(32):9857-9865. [doi:10.1021/bi060379n]
5. Cheng, M., Sexl, V., Sherr, C.J., Roussel, M.F., 1998. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). PNAS, 95(3):1091-1096. [doi:10.1073/pnas.95.3. 1091]
6. Cheng, X., Blumenthal, R.M., 2011. Introduction - epiphanies in epigenetics. Prog. Mol. Biol. Transl. Sci., 101:1-21. [doi:10.1016/B978-0-12- 387685-0.00001-9.
7. Cornwall, G.A., Collis, R., Xiao, Q., Hsia, N., Hann, S.R., 2001. B-myc, a proximal caput epididymal protein, is dependent on androgens and testicular factors for expression. Biol. Reprod., 64(6):1600-1607. [doi:10.1095/ biolreprod64.6.1600]
8. Facchini, L.M., Penn, L.Z., 1998. The molecular role of myc in growth and transformation: recent discoveries lead to new insights. FASEB J., 12(9):633-651.
9. Fausto, N., 2000. Liver regeneration. J. Hepatol., 32(1 Suppl.): 19-31. [doi:10.1016/S0168-8278(00)80412-2.
10. Fujiyoshi, M., Ozaki, M., 2011. Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases. J. Hepatobilliary Pancreat. Sci., 18(1):13-22. [doi:10.1007/s00534-010-0304-2.
11. Gregory, M.A., Xiao, Q., Cornwall, G.A., Lutterbach, B., Hann, S.R., 2000. B-myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation. Oncogene, 19(42):4886-4895. [doi:10.1038/sj. onc.1203851]
12. Gurvich, N., Tsygankova, O.M., Meinkoth, J.L., Klein, P.S., 2004. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res., 64(3):1079-1086. [doi:10.1158/0008-5472.CAN-03-0799.
13. Higgins, G.M., Anderson, R.M., 1931. Experimental pathology of the liver: restoration of the liver of the white rat following partial surgical removal. Arch. Pathol., 12:186-202.
14. Ingvarsson, S., Asker, C., Acelson, H., Klein, G., Sumegi, J., 1988. Structure and expression of B-myc, a new member of the myc gene family. Mol. Cell. Biol., 8(8):3168-3174. [doi:10.1128/MCB.8.8.3168]
15. Kaiser, M., Zavrski, I., Sterz, J., Jakob, C., Fleissner, C., Kloetzel, P.M., Sezer, O., Heider, U., 2006. The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma. Haematologica, 91(2):248-251.
16. Katsuyama, T., Paro, R., 2011. Epigenetic reprogramming during tissue regeneration. FEBS Lett., 585(11):1617-1624. [doi:10.1016/j.febslet.2011.05.010]
17. Ke, Q., Erbolat, Zhang, H.Y., Bu, H., Li, S., Shi, D.N., Yang, G.H., Chen, H.J., Wei, B., 2007. Clinicopathologic features of pleomorphic hyalinizing angiectatic tumor of soft parts. Chin. Med. J., 120(10):876-881.
18. Martín-Subero, J.I., Esteller, M., 2011. Profiling epigenetic alterations in disease. Adv. Exp. Med. Biol., 711:162-177. [doi:10.1007/978-1- 4419-8216-2-12]
19. Merion, R.M., 2010. Current status and future of liver transplantation. Semin. Liver Dis., 30(4):411-421. [doi:10. 1055/s-0030-1267541.
20. Michaelis, M., Michaelis, U.R., Fleming, I., Suhan, T., Cinatl, J., Blaheta, R.A., Hoffmann, K., Kotchetkov, R., Busse, R., Nau, H., et al., 2004. Valproic acid inhibits angiogenesis in vitro and in vivo. Mol. Pharmacol., 65(3): 520-527. [doi:10.1124/mol.65.3.520]
21. Mitchell, C., Willenbring, H., 2008. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc., 3(7):1167-1170. [doi:10.1038/nprot.2008.80]
22. Mongan, N.P., Gudas, L.J., 2005. Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'- deoxycytidine, restores expression of silenced RARβ2 in breast cancer cells. Mol. Cancer Ther., 4(3):477-486. [doi:10.1158/1535-7163.MCT-04-0079.
23. Nakayama, T., Takami, Y., 2001. Participation of histones and histone-modifying enzymes in cell functions through alterations in chromatin structure. J. Biochem., 129(4): 491-499. [doi:10.1093/oxfordjournals.jbchem. a002882]
24. Nelsen, C.J., Rickheim, D.G., Timchenko, N.A., Stanley, M.W., Albrecht, J.H., 2001. Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo. Cancer Res., 61(23):8564-8568.
25. Patil, M.A., Lee, S.A., Macias, E., Lam, E.T., Xu, C.R., Jones, K.D., Ho, C., Rodriguez-Puebla, M., Chen, X., 2009. Role of cyclin D1 as a mediator of c-Met- and β-catenin-induced hepatocarcinogenesis. Cancer Res., 69(1):253-261. [doi:10.1158/0008-5472.CAN-08-2514.
26. Resar, L.M., Dolde, C., Barret, J.F., Dang, C.V., 1993. B-myc inhibits neoplastic transformation and transcriptional activation by c-myc. Mol. Cell. Biol., 13(2):1130-1136. [doi:10.1128/MCB.13.2.1130]
27. Riehle, K.J., Dan, Y.Y., Campbell, J.S., Fausto, N., 2011. New concepts in liver regeneration. J. Gastroenterol. Hepatol., 26(7):1218. [doi:10.1111/j.1440-1746.2010.06539.x]
28. Rodríguez, J.L., Sandoval, J., Serviddio, G., Sastre, J., Morante, M., Perrelli, M.G., Martínez-Chantar, M.L., Viña, J., Viña, J.R., Mato, J.M., et al., 2006. Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration. Biochem. J., 398(3):431-437. [doi:10.1042/BJ20060380]
29. Sakamuro, D., Prendergast, G., 1999. New myc-interacting proteins: A second myc network emerges. Oncogene, 18(19):2942-2954. [doi:10.1038/sj.onc. 1202725]
30. Satyanarayana, A., Kaldis, P., 2009. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene, 28(33):2925-2939. [doi:10.1038/onc.2009.170]
31. Shen, S., Sandoval, J., Swiss, V.A., Li, J., Dupree, J., Franklin, R.J.M., Casaccia-Bonnefil, P., 2008. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat. Neurosci., 11(9): 1024-1034. [doi:10.1038/nn.2172]
32. Sherr, C.J., 1995. D-type cyclins. Trends Biochem. Sci., 20(5):187-190. [doi:10.1016/S0968-0004(00)89005-2.
33. Sherr, C.J., 2000. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res., 60(14):3689-3695.
34. Sherr, C.J., Roberts, J.M., 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev., 13(12):1501-1512. [doi:10.1101/gad.13.12.1501]
35. Simile, M.M., de Miglio, M.R., Muroni, M.R., Frau, M., Asara, G., Serra, S., Muntoni, M.D., Seddaiu, M.A., Daino, L., Feo, F., et al., 2004. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis, 25(3): 333-341. [doi:10.1093/carcin/bgh014]
36. Takai, N., Desmond, J.C., Kumagai, T., Gui, D., Said, J.W., Whittaker, S., Miyakawa, I., Koeffler, H.P., 2004. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. Clin. Cancer Res., 10(3):1141-1149. [doi:10.1158/1078-0432.CCR-03-0100.
37. Thiaqalinqam, S., Cheng, K.H., Lee, H.J., Mineva, N., Thiaqalingam, A., Ponte, J.F., 2003. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann. N. Y. Acad. Sci., 983(1):84-100. [doi:10.1111/j.1749-6632.2003.tb05964.x]
38. Turner, B.M., 2000. Histone acetylation and epigenetic code. Bioessays, 22(9):836-845. [doi:10.1002/1521-1878(200 009)22:9<836::AID-BIES9>3.0. CO;2-O]
39. Wang, G.L., Salisbury, E., Shi, X.R., Timchenko, L., Medrano, E.E., Timchenko, N.A., 2008a. HDAC1 cooperates with C/EBPα in the inhibition of liver proliferation in old mice. J. Biol. Chem., 283(38):26169-26178. [doi:10.1074/jbc. M803544200]
40. Wang, G.L., Salisbury, E., Shi, X.R., Timchenko, L., Medrano, E.E., Timchenko, N.A., 2008b. HDAC1 promotes liver proliferation in young mice via interactions with C/EBPβ. J. Biol. Chem., 283(38):26179-26187. [doi:10.1074/jbc. M803545200]
41. Zimmermann, A., 2004. Regulation of liver regeneration. Nephrol. Dial. Transplant., 19(Suppl. 4):iv6-iv10. [doi:10.1093/ndt/gfh1034]